New drug NSHO-101 put to the test in healthy volunteers
Knowledge-focused
Recruiting now
This early-stage study is testing a new drug called NSHO-101 in 24 healthy adults to see how the body handles it and whether it is safe. Participants will receive the drug and have their blood levels and any side effects monitored closely. This is a first step in human testing an…
Phase: PHASE1 • Sponsor: Ensho Therapeutics, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:04 UTC